Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
08/22/1996 | CA2212370A1 Inhibition of angiogenesis using interleukin-12 |
08/22/1996 | CA2211674A1 Alk(en)yl dicarboxylic acid bisesters, their use and method for preparing them |
08/21/1996 | EP0726956A1 Novel human transglutaminases |
08/21/1996 | EP0726911A1 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf |
08/21/1996 | EP0726895A1 Pseudodipeptide product having an imidazole grouping and applications |
08/21/1996 | EP0726773A1 Method for inhibiting angiogenesis using heparinase |
08/21/1996 | EP0726764A1 Multilamellar liposomal arachidonic acid metabolite formulations |
08/21/1996 | EP0726763A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations |
08/21/1996 | EP0614457B1 Leukotriene-b 4? derivatives, process for preparing the same and medicaments |
08/21/1996 | CN1129447A Tri-substituted imidazoles having multiple therapeutic properties |
08/21/1996 | CN1129441A Vitamin D analogues |
08/21/1996 | CN1129102A Catechol diether compounds as inhibitors of TNF release |
08/21/1996 | CN1129098A Composition for enhancing hair growth |
08/20/1996 | US5547971 Use of leflunomide for inhibiting interleukin 8 |
08/20/1996 | US5547853 CD2-binding domain of lymphocyte function associated antigen 3 |
08/20/1996 | US5547678 Mixture of kojic acid and sunscreen agent |
08/20/1996 | US5547662 Preparation of a skin surface for a surgical procedure |
08/15/1996 | WO1996024371A1 Multifunctional enzyme |
08/15/1996 | WO1996024359A1 Novel pharmaceutical formulation |
08/15/1996 | WO1996024350A1 Pharmaceutical preparations for tumour necrosis factor (tnf) inhibition |
08/15/1996 | WO1996011685A3 Use of indole derivatives for the treatment of various diseases |
08/15/1996 | CA2212533A1 Multifunctional enzyme |
08/15/1996 | CA2211409A1 Novel pharmaceutical formulation |
08/14/1996 | EP0726273A1 Tocophenylglycoxides, their preparation and use as tensides, as antioxidants and as cells altering prophylactics in cosmetic or pharmaceutical preparation |
08/14/1996 | EP0725796A1 Growth differentiation factor-10 |
08/14/1996 | EP0725772A1 Phytosphingosine-based ceramide i analogs |
08/14/1996 | EP0725635A1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
08/14/1996 | EP0725634A1 Plaster for the treatment of nail mycoses |
08/14/1996 | EP0636115B1 Novel bis-phenyl-hexenes |
08/14/1996 | CN1128660A Medicinal ointment for resolving blood stasis |
08/13/1996 | US5545669 Anti-inflammatory compounds |
08/13/1996 | US5545633 Triplet-sensitized photoisomerization; dehydration; protecting; deprotecting; separation |
08/13/1996 | US5545405 Administering recombinant antibody glycosylated by chinese hamster ovary cell |
08/13/1996 | US5545404 Method for treating a mammal suffering from a T-cell medicated disorder with a CHO-Glycosylated antibody |
08/13/1996 | US5545403 Method for treating a mammal by administering a CHO-glycosylated antibody |
08/08/1996 | WO1996023787A1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same |
08/08/1996 | WO1996023512A1 Extracts of shark cartilage, process of production and uses thereof |
08/08/1996 | WO1996023510A1 Effervescent composition containing iodinated polyvinylpyrrolidone, and use thereof for disinfection |
08/08/1996 | WO1996023505A1 Inhibition of the degradation of connective tissue matrix protein components in mammals |
08/08/1996 | WO1996023490A1 Formulations and methods for reducing skin irritation |
08/08/1996 | WO1996023489A2 Use of carotinoids for preparing medicaments for treating dermatoses |
08/08/1996 | WO1996023487A1 Medicament form for the delivery of collagenase to wounds and process for the preparation thereof |
08/08/1996 | WO1996023463A1 Transdermal formulation |
08/08/1996 | DE19503338A1 Arzneiform zur Abgabe von Kollagenase an Wunden und Verfahren zu ihrer Herstellung Dosage form for the delivery of collagenase to wounds and methods for their preparation |
08/08/1996 | CA2212127A1 Formulations and methods for reducing skin irritation |
08/08/1996 | CA2212059A1 Medicament form for the delivery of collagenase to wounds and process for the preparation thereof |
08/08/1996 | CA2211783A1 Inhibition of the degradation of connective tissue matrix protein components in mammals |
08/08/1996 | CA2211586A1 Effervescent composition containing iodinated polyvinylpyrrolidone, and use thereof for disinfection___________________________________________ |
08/08/1996 | CA2210957A1 The use of carotenoids for producing drugs for the treatment of dermatoses |
08/08/1996 | CA2210711A1 Transdermal formulation |
08/07/1996 | EP0724599A1 Platelet-derived growth factor analogues |
08/07/1996 | EP0724597A1 Ks-laminin and methods of use |
08/07/1996 | EP0724592A1 16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors |
08/07/1996 | EP0724566A1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation |
08/07/1996 | EP0724438A1 Ibuprofen and flurbiprofen as anti-pruritic agents |
08/07/1996 | CN1128263A Pyrrolopyrimidine derivatives having pharmacological activity |
08/07/1996 | CN1128262A Substituted biphenyl isoxazole sulfonamides |
08/06/1996 | US5543422 Heterocyclic amines |
08/06/1996 | US5543417 Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents |
08/06/1996 | US5543410 Pharmacological use of phthaloylhydrazide derivatives; combination and application thereof |
08/01/1996 | WO1996023068A1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses |
08/01/1996 | WO1996023067A1 Human interleukin-1 receptor accessory protein |
08/01/1996 | WO1996023065A2 Inhibition of neovascularization using vegf-specific oligonucleotides |
08/01/1996 | WO1996022985A1 2-(2-amino-3-methoxyphenyl)-4-oxo-4h-[1]benzopyran for treating proliferative disorders |
08/01/1996 | WO1996022776A1 Dermatological use of vitamin d derivatives |
08/01/1996 | WO1996022760A2 Antagonists of alpha-melanocyte stimulating hormone and methods based thereon |
08/01/1996 | CA2210884A1 Dermatological use of vitamin d derivatives |
08/01/1996 | CA2210737A1 Antagonists of alpha-melanocyte stimulating hormone and methods based thereon |
08/01/1996 | CA2210724A1 Human interleukin-1 receptor accessory protein |
08/01/1996 | CA2208075A1 2-(2-amino-3-methoxyphenyl)-4-oxo-4h-[1]benzopyran for treating proliferative disorders |
07/31/1996 | EP0723959A1 Heterocyclic compounds as tachykinin receptor antagonists, process for their preparation and pharmaceuticals containing them |
07/31/1996 | EP0723782A1 Use of a preparation comprising a plasminogen activator to improve wound healing |
07/31/1996 | EP0723781A2 Transdermal formulation of xanomeline |
07/31/1996 | EP0723778A1 Composition for modulation of apoptosis comprising a factor influencing the intracellular level of methional or malondialdehyde |
07/31/1996 | EP0723774A1 Cosmetic, dermatological or pharmaceutical composition comprising an antagonist of CGRP |
07/31/1996 | EP0723595A1 A novel nuclear mitotic phosphoprotein: mitosin |
07/31/1996 | EP0647219B1 Derivatives in the vitamin d series modified at the 20 position, a method of preparing such derivatives, intermediates used in this method, pharmaceutical preparations containing the derivatives and their use in the preparation of drugs |
07/31/1996 | CN1128047A Recombinant stratum corneum chymotryptic enzyme (SCCE) |
07/31/1996 | CN1127653A "Jiexuanling" medicine for treating scabies |
07/30/1996 | US5541219 Antiinflammatory agents; aids |
07/30/1996 | US5541202 New leukotriene-B4 Antagonists and their use as pharmaceutical agents |
07/30/1996 | US5541190 Treating benign prostatic hyperplasia, male pattern baldness, prostatic cancer, androgenic alopecia |
07/30/1996 | US5541183 Ginkgolide derivatives |
07/30/1996 | US5541073 Method of diagnosing epidermis differentiation disorders in a patient using a stratum corneum-specific antibody |
07/30/1996 | CA1338493C Bicyclic aromatic derivatives; process for preparing the same and their use in cosmetics |
07/25/1996 | WO1996022369A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
07/25/1996 | WO1996022306A1 Novel peptide |
07/25/1996 | WO1996022021A1 Protein hydroxylation inhibitors for fibroproliferative disorders |
07/25/1996 | CA2210885A1 Protein hydroxylation inhibitors for fibroproliferative disorders |
07/24/1996 | EP0723015A1 Novel modified PF4 compositions and methods of use |
07/24/1996 | EP0722928A1 Bicyclic-aromatic compounds with strong biologic activity, pharmaceutical and cosmetic compositions containing them and uses thereof |
07/24/1996 | EP0722736A1 Topical composition containing an antagonist of substance P |
07/24/1996 | EP0722722A1 Use of an antagonist of substance P for the treatment of cutaneous erythema of neurogenic origin |
07/24/1996 | EP0722715A1 Cosmetic compositions containing lactate dehydrogenase inhibitors |
07/24/1996 | EP0722451A1 Water-soluble retinoids |
07/24/1996 | EP0722448A1 O-aryl, o-alkyl, o-alkenyl and o-alkynyl-macrolides having immunosuppressive activity |
07/24/1996 | EP0722318A1 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
07/24/1996 | EP0581954B1 Use of alpha-hydroxyketoalkyl derivatives as protective light filters |
07/24/1996 | CN1127509A New peptide derivatives |
07/24/1996 | CN1127258A Novel a-nor-steroid-3-carboxylic acid derivatives |